An oral PARP inhibitor Zejula 100mg Capsule for advanced ovarian cancer along with fallopian tube and primary peritoneal cancers. It helps in the maintaining the treatment of these cancers. Mainly prescribed for patients who have responded to platinum based chemotherapy, regardless of BRCA mutations status. Monitoring is required on a regular basis. Thus it includes monitoring of regular blood counts due to risks of thrombocytopenia, anemia and hypertension. To know more detailed information about the medication visit Globans Pharma website.